arrow
D

Dimos D. Mitsikostas

aeginition hospital, medical school, national and kapodistrian university of athens
H指数:48
被引数:8,823

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

EMHA migraine scoring system: A novel, valid, and reliable metric to capture severity, align with patients, and facilitate communication

EMHA偏头痛评分系统:一种用于捕捉严重程度、与患者保持一致并促进沟通的新型、有效且可靠的指标

2026-09-020
PRE
Management of persistent idiopathic facial pain (PIFP) – An international Delphi study

持续性特发性面部疼痛(PIFP)的管理——一项国际德尔菲研究

2025-12-020
OA
Hallmarks of primary headache: part 3 – cluster headache

原发性头痛的特征:第三部分——丛集性头痛

2025-10-030
OA
Spontaneous Multiple Cervical Artery Dissections Detected with High-Resolution MRI: A Prospective, Case-Series Study

自发性多发性颈动脉夹层经高分辨率MRI检测:一项前瞻性病例系列研究

2025-10-010
OA
Long-term real-world effectiveness and safety of fremanezumab in 1140 patients with migraine and at least 6 months of treatment: third interim analysis of the pan-European PEARL study

fremanezumab在1140名偏头痛患者中的长期真实世界有效性与安全性(至少6个月治疗):欧洲泛欧PEARL研究的第三次中期分析

2025-10-010
OA
Efficacy and Safety of GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension: A Systematic Review and Meta-Analysis

GLP-1和双重GIP/GLP-1受体激动剂在特发性颅内高压中的有效性与安全性:一项系统评价和Meta分析

2025-09-120
PREAI
Unmet needs in the management of migraine in Greece from the perspective of medical experts: a Delphi consensus (vol 16, 1556808, 2025)

希腊医疗专家视角下偏头痛管理中的未满足需求:一项德尔菲共识(卷 16,1556808,2025)

2025-04-020
OA
Resistant and refractory migraine - two different entities with different comorbidities? Results from the REFINE study

耐药性和难治性偏头痛-具有不同合并症的两种不同实体?REFINE研究的结果

2024-12-030
OAAI
The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disorders

世界卫生组织关于癫痫和其他神经系统疾病和头痛革命的部门间全球行动计划: 从头痛负担到头痛疾病的全球行动计划

2024-01-0415
OAAI